HP Inc: Form 10-Q for the period ended Apr 30, 2024
Filed with the SEC on May 30, 2024 and accepted by EDGAR at May 29, 2024, 18:45 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-02-01 to 2024-04-30 | $12.80bn | us-gaap:Revenues |
| Revenue | 6 months2023-11-01 to 2024-04-30 | $25.98bn | us-gaap:Revenues |
| Cost of revenue | 3 months2024-02-01 to 2024-04-30 | $9.78bn | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-11-01 to 2024-04-30 | $20.07bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2024-02-01 to 2024-04-30 | $3.02bn | us-gaap:GrossProfit |
| Gross profit | 6 months2023-11-01 to 2024-04-30 | $5.91bn | us-gaap:GrossProfit |
| Research and development | 3 months2024-02-01 to 2024-04-30 | $436.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-11-01 to 2024-04-30 | $835.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2024-02-01 to 2024-04-30 | $1.46bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-11-01 to 2024-04-30 | $2.85bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-02-01 to 2024-04-30 | $952.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-11-01 to 2024-04-30 | $1.89bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-02-01 to 2024-04-30 | $190.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-11-01 to 2024-04-30 | $361.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-02-01 to 2024-04-30 | $607.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-11-01 to 2024-04-30 | $1.23bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-02-01 to 2024-04-30 | $0.61 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-11-01 to 2024-04-30 | $1.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-02-01 to 2024-04-30 | $0.62 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-11-01 to 2024-04-30 | $1.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-02-01 to 2024-04-30 | 990,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-11-01 to 2024-04-30 | 996,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-11-01 to 2024-04-30 | $702.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-11-01 to 2024-04-30 | $277.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2023-11-01 to 2024-04-30 | $544.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2024-02-01 to 2024-04-30 | $100.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Share repurchases | 6 months2023-11-01 to 2024-04-30 | $600.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-04-30 | $2.44bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-04-30 | $18.59bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-04-30 | $37.43bn | us-gaap:Assets |
| Current liabilities | At period end2024-04-30 | $24.84bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2024-04-30 | $9.33bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-04-30 | $199.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-04-30 | −$916.0m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2024-04-30 | 978,559,586 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000047217-24-000041. Last ingested by Listed: Nov 4, 2026, 17:49 ET. Listed shows no prices and gives no investment advice.